Explore more publications!

Telecoms Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecoms Today.

Press releases published on October 24, 2025

DebitMyData Addresses Global H20 Export Ban Crisis, Unveils Critical Role of the Human Energy Grid
DebitMyData Addresses Global H20 Export Ban Crisis, Unveils Critical Role of the Human Energy Grid
DebitMyData Addresses Global H20 Export Ban Crisis, Unveils Critical Role of the Human Energy Grid
Relax in Comfort Launches “Compare the Alternatives” Program to Help Compare Leading Adjustable Smart Mattresses
Blazpay Presale Explodes 74.6% as Bitcoin Consolidates Near $108K and Ethereum Dips Below $3,830
SLC Appoints Veena Dandapani as Chief Operating Officer to Drive Global Expansion and Advance SIM-Based Identity Innovation
BurnPeak Clinical Research: Burn Peak Triple-BHB Formula Shows 87% Response Rate in 312-Participant Study on Age-Related Metabolic Decline
Theriva Biologics Provides Response to Unusual Market Action
TR-1 Notification and Block Listing Return
Birnie Plumbing and Drains Becomes First Hamilton Company to Deploy LightRay UV Pipe Rehabilitation Technology
Cielo Confirms No Material Change
HII Successfully Completes Second Builder’s Sea Trials for Destroyer Ted Stevens (DDG 128)
Syndax Announces FDA Approval of Revuforj® (revumenib) in Adult and Pediatric Patients with Relapsed or Refractory NPM1 Mutated Acute Myeloid Leukemia
À venir… La Campagne nationale du coquelicot 2025 de la Légion
Coming up! Legion’s 2025 National Poppy Campaign
K12 Wins Two Silver Medals at 2025 International Serious Play Awards
Tensora Launched the First AI-Powered Layer 2 on BNB Chain — Bringing Decentralized Machine Intelligence On-Chain
Sionna Therapeutics Announces Presentation of SION-719 and SION-451 Phase 1 Data and Poster of New Preclinical Data on the Impact of NBD1 Stabilizers on F508del-CFTR Half-Life at the 2025 North American Cystic Fibrosis Conference
Cogent Biosciences Announces KRAS Poster Presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
BlossomHill Therapeutics Presents Preliminary Findings from Phase 1/2 SOLARA Trial of BH-30643 in EGFR-mutant NSCLC at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions